Stocks · US
ROIV
XNAS
Roivant Sciences Ltd. Common Shares
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B6.11x
P/S3,431.32x
EPS$-0.37
ROE-6.29%
ROA-5.02%
Dividend yield0.00%
Debt/Equity0.00
Free cash flow$-821M
Returns and 52-week range
1W-2.66%
1M+1.72%
3M-1.55%
6M+28.04%
1Y+119.73%
YTD+62.02%
52W high$42.50
52W low$15.90
From 52W high-16.40%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| West Pharmaceutical Services, Inc. | $26.5B | 46.94 | 8.87 | +9.61% |
| 퀘스트 다이어그노스틱스 | $25.6B | 24.20 | 3.41 | -3.69% |
| 앨나일램 파머슈티컬스 | $29.4B | 36.42 | 21.73 | -15.85% |
| Royalty Pharma plc Class A Ordinary Shares | $25.2B | 30.96 | 3.69 | -11.76% |
| ZOETIS INC. | $29.5B | 11.28 | 9.37 | -5.91% |
| 가단트 헬스 | $25.1B | — | — | +5.75% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.